Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IRADIMED CORP Director's Dealing 2022

Jan 4, 2022

32324_dirs_2022-01-04_472278e8-07d0-4ac4-ba8c-024aba632d75.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2021-12-27

Reporting Person: Susi Roger E. (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-12-27 Common Stock G 22600 Disposed 803450 Indirect
2021-12-27 Common Stock G 500 Disposed 802950 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2362500 Indirect
Common Stock 2362500 Indirect

Footnotes

F1: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose.